Tralokinumab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB12169 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | diabetic cataract | KG + DL |
| 2 | craniostenosis cataract | KG + DL |
| 3 | mature cataract | KG + DL |
| 4 | tetanic cataract | KG + DL |
| 5 | diabetes mellitus type 2 associated cataract | KG + DL |
| 6 | immature cataract | KG + DL |
| 7 | cortical cataract | KG + DL |
| 8 | nuclear senile cataract | KG + DL |
| 9 | senile cataract | KG + DL |
| 10 | diabetic retinopathy | KG + DL |
| 11 | severe nonproliferative diabetic retinopathy | KG + DL |
| 12 | antithrombin deficiency type 2 | KG + DL |
| 13 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 14 | heparin cofactor 2 deficiency | KG + DL |
| 15 | thrombophilia | KG + DL |
| 16 | hemorrhagic disease of newborn | KG + DL |
| 17 | diffuse gastric adenocarcinoma | KG + DL |
| 18 | gastric carcinoma | KG + DL |
| 19 | gastric adenocarcinoma and proximal polyposis of the stomach | KG + DL |
| 20 | signet ring cell gastric adenocarcinoma | KG + DL |
| 21 | gastric tubular adenocarcinoma | KG + DL |
| 22 | microinvasive gastric cancer | KG + DL |
| 23 | bronchitis | KG + DL |
| 24 | gastric cardia adenocarcinoma | KG + DL |
| 25 | microvascular complications of diabetes, susceptibility to | KG + DL |
| 26 | Epstein-Barr virus-associated carcinoma | KG + DL |
| 27 | malignant gastric granular cell tumor | KG + DL |
| 28 | cardia cancer | KG + DL |
| 29 | carcinoma in situ of gastric cardia | KG + DL |
| 30 | carcinoma in situ of gastric body | KG + DL |
| 31 | drug-induced osteoporosis | KG + DL |
| 32 | gastric lymphoma | KG + DL |
| 33 | malignant gastric germ cell tumor | KG + DL |
| 34 | pylorus cancer | KG + DL |
| 35 | benign neoplasm of stomach | KG + DL |
| 36 | bronchial adenomas/carcinoids childhood | KG + DL |
| 37 | non-seminomatous lesion | KG + DL |
| 38 | chondroid hamartoma | KG + DL |
| 39 | ductal or ductular proliferation | KG + DL |
| 40 | gastric neoplasm | KG + DL |
| 41 | gastric cancer | KG + DL |
| 42 | tumor of testis and paratestis | KG + DL |
| 43 | thyroglossal duct cyst | KG + DL |
| 44 | odontogenic cyst | KG + DL |
| 45 | mesenchymoma | KG + DL |
| 46 | cystic neoplasm | KG + DL |
| 47 | severe early-onset pulmonary alveolar proteinosis due to MARS deficiency | KG + DL |
| 48 | pre-malignant neoplasm | KG + DL |
| 49 | epiglottis neoplasm | KG + DL |
| 50 | benign neoplasm of tongue | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.